Navigation Links
Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market
Date:5/22/2008

Japanese Distributor to Expand Global Reach of Novel Technology

N. BILLERICA, Mass., May 22 /PRNewswire/ -- Seahorse Bioscience, leaders in real-time measurement of cellular bioenergetics, announced today that Primetech Corporation will become the exclusive supplier of Seahorse XF instruments and consumables in Japan.

"Japan's contribution to research and drug discovery is continuing to grow, as we have seen with the recent acquisition of Millennium by Takeda Pharmaceutical Company and with its increasing pipeline of new drugs in development," Mr. Ryosuke Ogihara, CEO of Primetech Corporation said. "Our customers are interested in studying mitochondrial dysfunction, and in particular its role in cancer, obesity and age-related diseases. Seahorse XF instruments offer the only practical way to study mitochondria in whole cells."

Introduced in June of 2006, Seahorse extracellular flux (XF) analyzers provide the first and only method to non-invasively measure the two major energy producing pathways -- mitochondrial respiration and glycolysis -- in living cells. The microplate-based technology allows scientists to assess the impact of drugs, genetic modifications and environment by monitoring the rate that cells consume oxygen and produce metabolic byproducts including acid and carbon dioxide.

"With a now well-established base of users in North America, we are expanding our reach to academic, biotech and pharma customers throughout the world" said Steve Chomicz, Vice President of Sales and Marketing at Seahorse. "We have chosen to work with Primetech after seeing their commitment to supporting their customers- an important factor in the introduction of innovative research instrumentation."

About Seahorse Bioscience, Inc.

Seahorse Bioscience is changing cancer, obesity, diabetes and age-related drug discovery programs the world over. Seahorse headquarters are located in North Billerica, Massachusetts. For more information, please visit http://www.seahorsebio.com.

About Primetech Corporation

For more than 15 years, Primetech Corporation has been a manufacturer and distributor of high technology medical and analytical science products throughout Japan. Primetech's focus on medical and analytical science products, a technically advanced staff, and an intimate knowledge of the Japanese marketplace allow it to assist companies in penetrating the Japanese market.

If you would like more information about Seahorse Bioscience, Inc., or would like to schedule a meeting with Steve Chomicz, please contact Kristine Hunt at 978-671-1610.


'/>"/>
SOURCE Seahorse Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ardea Biosciences Announces Upcoming Corporate Meetings
2. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
3. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
4. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
5. Numira Biosciences Names New Board Member
6. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
7. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
8. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation
9. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
10. Ardea Biosciences Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
11. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... announce that its fully redesigned website, which launched October 17, 2016, features comprehensive ... responsive design and easy-to-navigate layout. Visitors and patients can discover the latest clinical ...
(Date:12/7/2016)... ... 07, 2016 , ... 1105 Media’s Live From program has ... Awards competition. Live From won in the Use of Social Media category. The ... projects undertaken by the media industry’s most innovative marketing professionals. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare professionals to ... WellnessPro platform by expanding the treatment modalities available in a single device. ...
(Date:12/7/2016)... ... ... “Walking With God: Inspirational Lessons from My Life's Journey”: a sometimes serious, sometimes ... direction in their lives. “Walking With God: Inspirational Lessons from My Life's Journey” is ... , Sanford says, “I enjoy sharing the true stories in my book as ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Calif. , Dec. 6, 2016 /PRNewswire/ ... held, clinical-stage medical dermatology and aesthetics company, ... a privately held specialty pharmaceutical company focused ... inflammatory skin conditions, including psoriasis, atopic dermatitis ... the agreement, Sienna will make an undisclosed ...
(Date:12/6/2016)... Mass. , Dec. 6, 2016  Blueprint Medicines ... discovering and developing targeted kinase medicines for patients with ... an underwritten public offering of $125,000,000 million in shares ... to grant the underwriters a 30-day option to purchase ... of its common stock in connection with the public ...
(Date:12/6/2016)... Dec. 6, 2016  In response to the tragic ... every 25 minutes, a respected group of local and ... provide a holistic suite of services to help Medicaid-eligible ... on his own experience trying to help family and ... Justin Lanning launched 180 Health Partners ...
Breaking Medicine Technology: